A Study of Glycemic Control in Left Ventricular Assist
NCT: NCT05933161 · RECRUITING
Brief Summary
The study is being conducted to understand if the hemoglobin A1c, a measurement of control of blood sugars over a 3-month time, is valid in patients with Left Ventricular Assist Devices (LVADs) in place. To understand whether it is an adequate measurement, the investigators will compare the A1c to results from a continuous glucose monitor (CGM) measurement of blood sugars. By monitoring blood sugars continuously, the investigators will also assess whether they can get better control of blood sugars with a CGM, including avoiding low blood sugars.
Frequently Asked Questions
What is A Study of Glycemic Control in Left Ventricular Assist?
A Study of Glycemic Control in Left Ventricular Assist is a clinical trial registered under NCT05933161. Current status: RECRUITING.
What is the status of NCT05933161?
The current status of NCT05933161 (A Study of Glycemic Control in Left Ventricular Assist) is: RECRUITING.
When did A Study of Glycemic Control in Left Ventricular Assist start?
A Study of Glycemic Control in Left Ventricular Assist started on 2023-11-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.